List of articles with "Thousand Oaks"

Amgen at Healthcare Conference

Amgen at Healthcare Conference

United States healthcare Amgen Thousand Oaks Conference
Amgen's $300M Boost

Amgen's $300M Boost

United States Puerto Rico Amgen Thousand Oaks Biomanufacturing
Amgen's Q1 2026 Insights

Amgen's Q1 2026 Insights

United States healthcare financial results Amgen Thousand Oaks
San Diego Students Excel

San Diego Students Excel

United States Thousand Oaks GSDSEF ISEF California Science Fair
Amgen's Leadership Change

Amgen's Leadership Change

USA biotechnology Amgen Thousand Oaks David Reese
New Flagship Academy

New Flagship Academy

United States Thousand Oaks Little Kitchen Academy Montessori Cooking
TEPEZZA Phase 3 Results

TEPEZZA Phase 3 Results

United States Amgen Thousand Oaks Thyroid Eye Disease TEPEZZA
Revolutionizing Retail Culture

Revolutionizing Retail Culture

USA Easton DICK'S Sporting Goods Thousand Oaks Spring Break Collection
Repatha® Reduces CV Risks

Repatha® Reduces CV Risks

USA Amgen Thousand Oaks Repatha CVS
Easton Joins Cosmic League

Easton Joins Cosmic League

United States Thousand Oaks Cosmic Baseball Easton Sports Chili Peppers
Amgen at 2026 Global Healthcare

Amgen at 2026 Global Healthcare

United States Innovation Healthcare Conference Amgen Thousand Oaks
Amgen Dividend Update

Amgen Dividend Update

USA Dividend biotechnology Amgen Thousand Oaks
Amgen at TD Cowen Conference

Amgen at TD Cowen Conference

United States Amgen Thousand Oaks Health Care TD Cowen
Amgen's UPLIZNA® Approved

Amgen's UPLIZNA® Approved

Amgen Thousand Oaks Czech Republic Myasthenia Gravis UPLIZNA
UPLIZNA® Approval

UPLIZNA® Approval

United Kingdom Amgen Thousand Oaks GMG UPLIZNA®
Amgen's 2025 Growth Report

Amgen's 2025 Growth Report

United States financial results revenue growth Amgen Thousand Oaks
Anchor Loans' 2025 Milestone

Anchor Loans' 2025 Milestone

United States Real Estate Thousand Oaks Housing Finance Anchor Loans
Amgen Presents at Conference

Amgen Presents at Conference

United States Healthcare Conference J.P. Morgan Amgen Thousand Oaks
Amgen Acquires Dark Blue

Amgen Acquires Dark Blue

United States oncology Amgen Thousand Oaks Dark Blue Therapeutics
Amgen's Commitment to Affordable Medicines

Amgen's Commitment to Affordable Medicines

United States healthcare Amgen Thousand Oaks Drug Pricing
UPLIZNA® Approved

UPLIZNA® Approved

United States Amgen Thousand Oaks Myasthenia Gravis UPLIZNA
Amgen 2026 Dividend

Amgen 2026 Dividend

United States Dividend Amgen Thousand Oaks NASDAQ:AMGN
IMDELLTRA® FDA Approval

IMDELLTRA® FDA Approval

Amgen Thousand Oaks SCLC IMDELLTRA
Amgen's Dividend Announcement

Amgen's Dividend Announcement

United States Dividend biotechnology Amgen Thousand Oaks
TEZSPIRE® Approval

TEZSPIRE® Approval

United States Amgen Thousand Oaks TEZSPIRE Allergy
Most Loved Workplaces

Most Loved Workplaces

United States Thousand Oaks Most Loved Workplaces Employee Satisfaction Lightfully Behavioral
Lindsey Carnett Keynotes

Lindsey Carnett Keynotes

USA Thousand Oaks California Lutheran University Marketing Maven Lindsey Carnett
AmgenNow Program

AmgenNow Program

USA Amgen Thousand Oaks Repatha AmgenNow
Repatha Trial Results

Repatha Trial Results

USA Amgen Thousand Oaks Repatha VESALIUS-CV
Amgen’s $650M Expansion

Amgen’s $650M Expansion

USA biopharmaceuticals Amgen Thousand Oaks USA manufacturing
Carnett's New Role

Carnett's New Role

United States Thousand Oaks American Cancer Society Relay For Life Lindsey Carnett
2025 Relay For Life

2025 Relay For Life

United States Thousand Oaks American Cancer Society Conejo Valley Relay For Life
Rocatinlimab Phase 3 Results

Rocatinlimab Phase 3 Results

USA Amgen Thousand Oaks Kyowa Kirin Rocatinlimab
Fitness Leadership Enhancement

Fitness Leadership Enhancement

USA Thousand Oaks 24 Hour Fitness ISSA Personal Trainers
Karen Hjerleid Joins Lightfully

Karen Hjerleid Joins Lightfully

United States mental health Thousand Oaks Lightfully Health Karen Hjerleid
Amgen's Major Investment

Amgen's Major Investment

United States Innovation Amgen Thousand Oaks Biopharmaceutical
Britt Freiden CSO

Britt Freiden CSO

United States mental health Thousand Oaks Lightfully Behavioral Health Britt Freiden
Repatha Approval Expanded

Repatha Approval Expanded

United States Amgen Thousand Oaks Repatha LDL Cholesterol
Visit Conejo Valley

Visit Conejo Valley

USA Thousand Oaks Agoura Hills Conejo Valley
Fantasy Camp for LA Youth

Fantasy Camp for LA Youth

United States Thousand Oaks 24 Hour Fitness Angel City FC LA Youth
Amgen Second Quarter 2025

Amgen Second Quarter 2025

USA Amgen Thousand Oaks Repatha TAVNEOS
Amgen's Q3 2025 Dividend

Amgen's Q3 2025 Dividend

United States Dividend biotechnology Amgen Thousand Oaks
Voyage Veterinary Advisors

Voyage Veterinary Advisors

USA Thousand Oaks Veterinary Advisors Practice Sales Transition Support
Amgen's Bemarituzumab Trial Results

Amgen's Bemarituzumab Trial Results

United States Amgen Thousand Oaks gastric cancer Bemarituzumab
Barry Sanders & Cholesterol

Barry Sanders & Cholesterol

USA Amgen Thousand Oaks Barry Sanders Cholesterol
IMDELLTRA® Breakthrough

IMDELLTRA® Breakthrough

United States Amgen Thousand Oaks small cell lung cancer IMDELLTRA®
GSD Expands Los Angeles

GSD Expands Los Angeles

United States Thousand Oaks Golden State Dermatology Dr. Peterson Pierre
IMDELLTRA® and SCLC

IMDELLTRA® and SCLC

USA Amgen Thousand Oaks SCLC IMDELLTRA
CAP-003 Data Release

CAP-003 Data Release

USA Thousand Oaks Parkinson's Capsida CAP-003
Latigo Biotherapeutics Funding

Latigo Biotherapeutics Funding

United States Pain Management Thousand Oaks Latigo Biotherapeutics Nav1.8 Inhibitor

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.